Can 'eugenics' be defended? - PubMed (original) (raw)

Can 'eugenics' be defended?

Walter Veit et al. Monash Bioeth Rev. 2021 Jul.

Abstract

In recent years, bioethical discourse around the topic of 'genetic enhancement' has become increasingly politicized. We fear there is too much focus on the semantic question of whether we should call particular practices and emerging bio-technologies such as CRISPR 'eugenics', rather than the more important question of how we should view them from the perspective of ethics and policy. Here, we address the question of whether 'eugenics' can be defended and how proponents and critics of enhancement should engage with each other.

Keywords: CRISPR; Embryo selection; Enhancement; Ethics; Eugenics; Gene editing; Human enhancement.

© 2021. The Author(s).

PubMed Disclaimer

Conflict of interest statement

None.

Similar articles

• Eugenics offended.
  Wilson RA. Wilson RA. Monash Bioeth Rev. 2021 Oct;39(2):169-176. doi: 10.1007/s40592-021-00145-1. Epub 2021 Dec 15. Monash Bioeth Rev. 2021. PMID: 34913155
• Shaping the CRISPR Gene-Editing Debate: Questions About Enhancement and Germline Modification.
  Johnston J. Johnston J. Perspect Biol Med. 2020;63(1):141-154. doi: 10.1353/pbm.2020.0011. Perspect Biol Med. 2020. PMID: 32063593
• In vitro eugenics.
  Sparrow R. Sparrow R. J Med Ethics. 2014 Nov;40(11):725-31. doi: 10.1136/medethics-2012-101200. Epub 2013 Apr 4. J Med Ethics. 2014. PMID: 23557913
• [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
  Sun SJ, Huo JH, Geng ZJ, Sun XY, Fu XB. Sun SJ, et al. Zhonghua Shao Shang Za Zhi. 2018 Apr 20;34(4):253-256. doi: 10.3760/cma.j.issn.1009-2587.2018.04.013. Zhonghua Shao Shang Za Zhi. 2018. PMID: 29690746 Review. Chinese.
• CRISPR technologies for bacterial systems: Current achievements and future directions.
  Choi KR, Lee SY. Choi KR, et al. Biotechnol Adv. 2016 Nov 15;34(7):1180-1209. doi: 10.1016/j.biotechadv.2016.08.002. Epub 2016 Aug 24. Biotechnol Adv. 2016. PMID: 27566508 Review.

Cited by

• Modular Ontologies for Genetically Modified People and their Bioethical Implications.
  So D, Sladek R, Joly Y. So D, et al. Nanoethics. 2024;18(2):9. doi: 10.1007/s11569-024-00459-4. Epub 2024 Aug 19. Nanoethics. 2024. PMID: 39170757 Free PMC article.
• Screening embryos for polygenic disease risk: a review of epidemiological, clinical, and ethical considerations.
  Capalbo A, de Wert G, Mertes H, Klausner L, Coonen E, Spinella F, Van de Velde H, Viville S, Sermon K, Vermeulen N, Lencz T, Carmi S. Capalbo A, et al. Hum Reprod Update. 2024 Oct 1;30(5):529-557. doi: 10.1093/humupd/dmae012. Hum Reprod Update. 2024. PMID: 38805697 Free PMC article. Review.

References

1. 1. Agar N. Liberal Eugenics. Public Affairs Quarterly. 1998;12(2):137–155. - PubMed
2. 1. Agar N. Liberal eugenics: In defence of human enhancement. New Jersey: Wiley; 2004.
3. 1. Agar N. Why we should defend gene editing as eugenics. Cambridge Quarterly of Healthcare Ethics. 2019;28(1):9–19. doi: 10.1017/S0963180118000336. - DOI - PubMed
4. 1. Anomaly J. Defending eugenics: From cryptic choice to conscious selection. Monash Bioethics Review. 2018;35(1–4):24–35. doi: 10.1007/s40592-018-0081-2. - DOI - PMC - PubMed
5. 1. Anomaly J. Creating future people: The ethics of genetic enhancement. London: Routledge; 2020.

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Archivio Istituzionale della Ricerca Unimi - Access Free Full Text
  • Europe PubMed Central
  • PubMed Central
  • Springer

• Other Literature Sources

  • scite Smart Citations

• Miscellaneous

  • NCI CPTAC Assay Portal